Högl, B.; Rothdach, A.; Wetter, T. C.; Trenkwalder, C.: Effects of cabergoline on sleep and morning motor performance in patients with Parkinson′s disease. European Journal of Neurology 6, pp. S 25 - S 29 (1999)

Holsboer, F.: Neuroendocrine studies and antidepressant drug development. Lecture on occasion of the meeting of the Japanese Society of Psychiatry and Neurology. Psychiatria et Neurologia Japonica 101, pp. 711 - 726 (1999)

Holsboer, F.: The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. Journal of Psychiatric Research 33, pp. 181 - 214 (1999)

Hölter, S. M.; Spanagel, R.: The effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145, pp. 360 - 369 (1999)

Jones, R. A.: Origin of the signal undershoot in BOLD studies of the visual cortex. NMR in Biomedicine 12, pp. 299 - 308 (1999)

Kessler, R. C.; DuPont, R. L.; Berglund, P.; Wittchen, H.-U.: Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two National Surveys. American Journal of Psychiatry 156, pp. 1663 - 1678 (1999)

Kessler, R. C.; Stang, P.; Wittchen, H.-U.; Stein, M.; Walters, E. E.: Lifetime comorbidities between social phobia and mood disorders in the U. S. National Comorbidity Survey. Psychological Medicine 29, pp. 555 - 567 (1999)

Koob, G. F.; Weiss, F.; Tiffany, S.; Zieglgänsberger, W.; Spanagel, R.: Animal models of craving. Alcohol Research & Health 23, pp. 233 - 236 (1999)

Korali, Z.; Stalla, G. K.: Klinik, Diagnostik und Therapie von Hypophysenadenomen. Klinikarzt 5, pp. 119 - 124 (1999)

Kovalovsky, D.; Paez Pereda, M.; Stalla, G. K.; Holsboer, F.; Arzt, E.: Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides ACTH and β-endorphin. Neuroimmunomodulation 6, pp. 367 - 372 (1999)

Kraft, E.; Schwarz, J.; Trenkwalder, C.; Vogl, T.; Pfluger, T.; Oertel, W. H.: The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences. Archives of Neurology 56, pp. 225 - 228 (1999)

Kraft, E.; Trenkwalder, C.; Then Bergh, F.; Auer, D.: Magnetic resonance proton spectroscopy of the brain in Wilson′s disease. Journal of Neurology 246, pp. 693 - 699 (1999)

Kraft, E.; Winkelmann, J.; Trenkwalder, C.; Auer, D.: Visual halucinations, white matter lesions and disease severity in Parkinson′s disease. Acta Neurologica Scandinavica 99, pp. 362 - 367 (1999)

Kraus, T.; Haack, M.; Schuld, A.; Hinze-Selch, D.; Kühn, M.; Uhr, M.; Pollmächer, T.: Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry 156, pp. 312 - 314 (1999)

Kraus, T.; Schuld, A.; Pollmächer, T.: Periodic leg movements and restless legs syndrome probably caused by olanzapine. Journal of Clinical Psychopharmacology 19, pp. 478 - 479 (1999)

Kümpfel, T.; Then Bergh, F.; Friess, E.; Uhr, M.; Yassouridis, A.; Trenkwalder, C.; Holsboer, F.: Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 70, pp. 431 - 438 (1999)

Lancel, M.: Role of GABA_A receptors in the regulation of sleep: Initial responses to peripherally administered modulators and agonists. Sleep 22, pp. 33 - 42 (1999)

Lancel, M.; Faulhaber, J.; Holsboer, F.; Rupprecht, R.: The GABA_A receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone. Psychopharmacology 141, pp. 213 - 219 (1999)

Lancel, M.; Steiger, A.: Schlaf und seine pharmakologische Beinflussung über den GABA_A Rezeptor. Angewandte Chemie 111, pp. 3024 - 3037 (1999)

Lancel, M.; Steiger, A.: Schlaf und seine pharmakologische Beinflussung über den GABA_A Rezeptor. Angewandte Chemie, International Edition 111, pp. 2852 - 2864 (1999)